Point72 Asia (Singapore) Pte. Ltd. Cytokinetics Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 1,849 shares of CYTK stock, worth $84,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,849Holding current value
$84,000% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$667 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$488 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$129 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.28B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...